Top

Supportive Care in Cancer

Published in:

01-03-2008 | Original Article

Self-reported taste and smell changes during cancer chemotherapy

Authors: Britt-Marie Bernhardson, Carol Tishelman, Lars E. Rutqvist

Published in: Supportive Care in Cancer | Issue 3/2008

Abstract

Purpose

This study explores the prevalence of self-reported taste and smell changes (TSCs) during chemotherapy and relationships between TSCs and demographic and clinical factors.

Materials and methods

Consecutive patients who had received chemotherapy for ≥6 weeks at 11 outpatient chemotherapy units completed a questionnaire developed for this survey.

Results

Seventy-five percent of the 518 participants reported TSCs, with TSCs more prevalent among women and younger patients. After adjustment for age and sex, we found that patients reporting TSCs more often reported: previous smell changes, less responsibility for cooking, concurrent medication, higher educational levels, and being on sick leave. Participants reporting oral problems, nausea, appetite loss, and depressed mood more frequently reported TSCs. Diagnosis and type of chemotherapy regimen did not predict TSCs.

Conclusion

TSCs were found to be common during cancer chemotherapy and were related to sociodemographic rather than clinical factors. TSCs were also found to be closely related to many other side effects of chemotherapy.

Most frequent medications (excluding antiemetics) were painkillers (69), antihypertensives (64), proton-pump inhibitors (59), cardiac medications (58), levotyroxin (39), antidepressants (34), diuretics (27), and anticoagulants (24).

Bartoshuk LM (1990) Chemosensory alterations and cancer therapies. NCI Monogr 9:179–184PubMed

Bernhardson BM, Tishelman C, Rutqvist LE (2007) Chemosensory changes experienced by patients undergoing cancer chemotherapy: a qualitative interview study. J Pain Symptom Manage (in press).

Berteretche MV, Dalix AM, d’Ornano AM, Bellisle F, Khayat D, Faurion A (2004) Decreased taste sensitivity in cancer patients under chemotherapy. Support Care Cancer 12(8):571–576PubMedCrossRef

Bramerson A, Johansson L, Ek L, Nordin S, Bende M (2004) Prevalence of olfactory dysfunction: the skovde population-based study. Laryngoscope 114(4):733–737PubMedCrossRef

Cameron B, Quested Evans (2003) A matter of taste: the experience of chemotherapy related taste changes. Aust J Cancer Nursing 4(1):3–9

Carelle NPE, Bellanger A, Germanaud J, Thuillier A, Khayat D (2002) Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 95(1):155–163PubMedCrossRef

Collins D (2003) Pretesting survey instruments: an overview of cognitive methods. Qual Life Res 12(3):229–238PubMedCrossRef

Doty RL, Bromley SM (2004) Effects of drugs on olfaction and taste. Otolaryngol Clin North Am 37(6):1229–1254PubMedCrossRef

Duffy V, Fast K, Lucchina L, Bartoshuk L (2002) Oral sensation and cancer. In: Berger A, Portenoy R, Weissman D (eds) Principles and practice of palliative care and supportive oncology. Lippincott Williams and Wilkins, Philadelphia, pp 178–193

10.

Epstein JB, Phillips N, Parry J, Epstein MS, Nevill T, Stevenson-Moore P (2002) Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 30(11):785–792PubMedCrossRef

11.

Foltz AT, Gaines G, Gullatte M (1996) Recalled side effects and self-care actions of patients receiving inpatient chemotherapy. Oncol Nurs Forum 23(4):679–683PubMed

12.

Frasnelli JTH (2004) Olfactory dysfunction and daily life. Eur Arch Oto-Rhino-Laryngol Hand Neck 265(3):231–235

13.

Griffin AM, Butow PN, Coates AS, Childs AM, Ellis PM, Dunn SM, Tattersall MH (1996) On the receiving end. V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 7(2):189–195PubMed

14.

Higgins SC, Montgomery GH, Bovbjerg DH (2007) Distress before chemotherapy predicts delayed but not acute nausea. Support Care Cancer 15:171–177PubMedCrossRef

15.

Jobe JB, Mingay DJ (1989) Cognitive research improves questionnaires. Am J Public Health 79(8):1053–1055PubMed

16.

Jordan K, Schmoll HJ, Aapro MS (2007) Comparative activity of antiemetic drugs. Crit Rev Oncol Hematol 61(2):162–175PubMedCrossRef

17.

Kim HJ, McGuire DB, Tulman L, Barsevick AM (2005) Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs 28(4):270–282 (quiz 283–4)PubMedCrossRef

18.

Lindley C, McCune JS, Thomason TE, Lauder D, Sauls A, Adkins S, Sawyer WT (1999) Perception of chemotherapy side effects cancer versus noncancer patients. Cancer Pract 7(2):59–65PubMedCrossRef

19.

Mattsson T, Arvidson K, Heimdahl A, Ljungman P, Dahllof G, Ringden O (1992) Alterations in taste acuity associated with allogeneic bone marrow transplantation. J Oral Pathol Med 21(1):33–37PubMedCrossRef

20.

Miller M, Kearney N (2004) Chemotherapy-related nausea and vomiting-past reflections, present practice and future management. Eur J Cancer Care (Engl) 13(1):71–81CrossRef

21.

Mulder NH, Smit JM, Kreumer WM, Bouman J, Sleijfer DT, Veeger W, Schraffordt Koops H (1983) Effect of chemotherapy on taste sensation in patients with disseminated malignant melanoma. Oncology 40(1):36–38PubMedCrossRef

22.

Nail LM, Jones LS, Greene D, Schipper DL, Jensen R (1991) Use and perceived efficacy of self-care activities in patients receiving chemotherapy. Oncol Nurs Forum 18(5):883–887PubMed

23.

Nordin S, Bramerson A, Murphy C, Bende M (2003) A Scandinavian adaptation of the Multi-Clinic Smell and Taste Questionnaire: evaluation of questions about olfaction. Acta Otolaryngol 123(4):536–542PubMedCrossRef

24.

Olofsson JK, Nordin S (2004) Gender differences in chemosensory perception and event-related potentials. Chem Senses 29(7):629–637PubMedCrossRef

25.

Rhodes VA, McDaniel RW, Hanson B, Markway E, Johnson M (1994) Sensory perception of patients on selected antineoplastic chemotherapy protocols. Cancer Nurs 17(1):45–51PubMedCrossRef

26.

Schiffman SS (1997) Taste and smell losses in normal aging and disease. Jama 278(16):1357–1362PubMedCrossRef

27.

Schiffman SS, Gatlin CA (1993) Clinical physiology of taste and smell. Annu Rev Nutr 13:405–436PubMedCrossRef

28.

Sherry VW (2002) Taste alterations among patients with cancer. Clin J Oncol Nurs 6(2):73–77PubMedCrossRef

29.

Sitzia J, North C, Stanley J, Winterberg N (1997) Side effects of CHOP in the treatment of non-Hodgkin’s lymphoma. Cancer Nurs 20(6):430–439PubMedCrossRef

30.

Thorne S, Kirkham S, MacDonald-Emes J (1997) Interpretive description: a noncategorical qualitative alternative for developing nursing knowledge. Res Nurs Health 20:169–177PubMedCrossRef

31.

Thorne S, O’Flynn-Magee K (2004) The analytic challenge in interpretive description. Int J Qual Methods 3(1):1–21

32.

Wickham RS, Rehwaldt M, Kefer C, Shott S, Abbas K, Glynn-Tucker E, Potter C, Blendowski C (1999) Taste changes experienced by patients receiving chemotherapy. Oncol Nurs Forum 26(4):697–706PubMed

33.

Youngblood M, Williams PD, Eyles H, Waring J, Runyon S (1994) A comparison of two methods of assessing cancer therapy-related symptoms. Cancer Nurs 17(1):37–44PubMedCrossRef

Title: Self-reported taste and smell changes during cancer chemotherapy
Authors: Britt-Marie Bernhardson
Carol Tishelman
Lars E. Rutqvist
Publication date: 01-03-2008
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 3/2008
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-007-0319-7

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2008

Cancer-related fatigue—new theories?

Possible links between behavioral and physiological indices of tiredness, fatigue, and exhaustion in advanced cancer

Erectile dysfunction in successfully treated lymphoma patients

Multinational Association of Supportive Care in Cancer

The relationship between insomnia and patient satisfaction with quality of life in cancer

Cultural aspects of communication in cancer care

Keynote webinar | Spotlight on antibody–drug conjugates in cancer